ACCOR ex. Doc de r.f GB
ACCOR ex. Doc de r.f GB
ACCOR ex. Doc de r.f GB
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The Meeting is also called upon to officially take note<br />
that the terms of office of one Statutory Auditor and its<br />
Alternate (Cabinet Janny Marque & Associés and<br />
Mr. Jean Coutancier, respectively) were not renewed<br />
upon <strong>ex</strong>piration at the last Ordinary Meeting of the<br />
Sharehol<strong>de</strong>rs (eighth resolution).<br />
Authorization to Management Board<br />
to issue bonds<br />
The Ordinary Meeting of the Sharehol<strong>de</strong>rs of June 16,<br />
1995 authorized the Company to issue bonds for a period<br />
of five years, enabling Accor to float three issues:<br />
- in December 1995, a FRF 1.5 billion (€ 228.7 million)<br />
bond issue with an interest rate of 7.40%,<br />
- in July 1998, a FRF 800 million (€ 122 million) zerocoupon<br />
bond issue ind<strong>ex</strong>ed to Accor stock, and<br />
- recently, in March 1999, a € 433.48 million bond<br />
<strong>ex</strong>changeable for shares of Compass stock, with an<br />
interest rate of 1%.<br />
The Meeting is asked to renew that authorization in<br />
advance for the five-year period provi<strong>de</strong>d by law, thereby<br />
enabling the Management Board to issue bonds in France<br />
or abroad up to a par value of € 2.5 billion or the<br />
equivalent in other currency, to meet the Company’s<br />
financing needs and take advantage of opportunities<br />
presented by financial markets.<br />
If approved, the <strong>de</strong>benture will be represented by bond<br />
certificates, subordinated perpetual bonds (TSDI), or<br />
bonds with warrants for the subscription of other straight<br />
bonds or bonds <strong>ex</strong>changeable for a variety of securities<br />
issued by others.<br />
This authorization is covered by the ninth resolution<br />
recommen<strong>de</strong>d to the Meeting for vote, and shall invalidate<br />
and superse<strong>de</strong> the fourteenth resolution of the Ordinary<br />
Meeting of the Sharehol<strong>de</strong>rs of June 7, 1995.<br />
Authorization to Management Board<br />
to tra<strong>de</strong> in Company stock<br />
The Extraordinary Sharehol<strong>de</strong>rs’ Meeting of June 9, 1998<br />
authorized the Management Board to tra<strong>de</strong> Company<br />
stock on the Stock Exchange within the meaning of<br />
Articles 217-2 and seq. of the French Business<br />
Corporations Act, at a purchase price of up to FRF 2,000<br />
and a selling price of no less than FRF 800.<br />
Pursuant to that authorization, the Company bought<br />
stock on the Stock Exchange in 1998 to smooth out<br />
share price movement.<br />
The Company bought 47,500 shares at an average price<br />
of FRF 1,370.93 per share, paying FRF 247,600.43 in<br />
commissions. The Company has not resold the shares,<br />
so on December 31, 1998 it held 47,500 shares of its<br />
own stock, each with a par value of FRF 100, for a total<br />
of FRF 65,119,175 comprising 0.13% of the capital<br />
stock on that date.<br />
The Meeting is asked to renew the authorization granted<br />
to the Management Board to tra<strong>de</strong> in Company stock<br />
un<strong>de</strong>r the new statutes and regulations governing such<br />
transactions, as <strong>de</strong>scribed in the prospectus approved<br />
by the French Securities and Exchange Commission and<br />
issued by the Company. The goals of the stock<br />
re<strong>de</strong>mption program are set forth in the prospectus and<br />
the tenth resolution submitted to the Meeting for vote.<br />
The authorization shall remain in effect for eighteen months.<br />
The purchase price shall be no higher than € 305, and<br />
the selling price shall be no lower than € 125.<br />
The Company limits the number of shares of stock that<br />
can be acquired un<strong>de</strong>r this authorization to 2,700,000,<br />
for a total amount of € 823,500,000. In its annual report<br />
to the Meeting of the Sharehol<strong>de</strong>rs, the Management<br />
Board shall account for how it has utilized said<br />
authorization.<br />
MANAGEMENT REPORT<br />
21